Accessibility Menu
TerrAscend logo

TerrAscend(TSX) TSND

Market CapCA$259.71MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2017)-31%
5 Year-91%
1 Year-39%
1 Month+9%
CA$0.84
+0.60%
+0.00Today
TerrAscend last closing stock price
MetricPriceDate
Last closeCAD 0.842026-08-20
TerrAscend stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+3.7%CAD 0.812026-08-13
1 month+9.09%CAD 0.772026-07-21
3 month-4.55%CAD 0.882026-05-22
Year to date-15.15%CAD 0.992025-12-31
1 year-38.69%CAD 1.372025-08-20
3 year-64.41%CAD 2.362023-08-21
5 year-90.72%CAD 9.052021-08-20
Since inception-31.4%CAD 1.212017-05-03

TerrAscend Financials at a Glance

Market Cap

CA$259.71MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$262.12M

Net Income (TTM)

-$41.07M

EPS (TTM)

-CA$0.19

P/E Ratio

-4.52

Dividend

CA$0.00

Beta (Volatility)

1.30 (Average)

Price

CA$0.84

Volume

179,125

Open

CA$0.84

Previous Close

CA$0.84

Daily Range

CA$0.81 - CA$0.84

52-Week Range

CA$0.53 - CA$2.00

Estimated Earnings Date

Nov 5, 2026

TSND News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About TerrAscend

TerrAscend Corp. operates as a comprehensive cannabis enterprise, engaging in the cultivation, processing, and distribution of cannabis products for both medical and regulated adult recreational markets across Canada and the United States. The company also develops and supplies hemp-derived wellness items and crafts specialty cannabis-infused edibles.

Products and Services
  • Cultivation and distribution of cannabis products
  • Hemp-derived wellness items for retail outlets
  • Specialty cannabis-infused edibles
Growth Outlook
  • Revenue of $65.39 million in Q2 2026, showing strong market demand
  • Gross profit margin of 52.09% indicates effective cost management
  • Expansion of retail dispensaries under The Apothecarium brand enhances market presence
Financial Highlights
  • Trailing twelve months (TTM) revenue of $263.5 million reflects consistent growth
  • Operating income margin of 18.05% demonstrates operational efficiency
  • Cash and cash equivalents of $41.96 million provide liquidity for future investments
TerrAscend Corp. is positioned as a key player in the cannabis industry, with a diverse portfolio that includes cultivation, processing, and retail operations. The company's focus on both medical and recreational markets allows for a broad customer base, while its commitment to quality and innovation in product offerings enhances its competitive edge. Recent financial performance indicates a solid revenue stream and effective cost management, which are critical for sustaining growth in a rapidly evolving market. The expansion of retail dispensaries further strengthens the company's market presence, making it an attractive option for potential investors interested in the cannabis sector.
AI Generated • Aug 12, 2026

Industry

Pharmaceuticals

Sector

Health Care

Employees

1,038

CEO

Ziad Ghanem, PharmD

Website

www.terrascend.com

Headquarters

Mississauga, ON L5B 1M5, CA

TSND Financials

Key Financial Metrics (TTM)

Gross Margin

51.16%

Operating Margin

17.05%

Net Income Margin

-15.67%

Return on Equity

-45.81%

Return on Capital

12.83%

Return on Assets

-7.43%

Earnings Yield

-22.12%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

CA$259.71MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

309.18M

Volume

179.13K

Avg. Volume

188.27K

Financials (TTM)

Gross Profit

$134.10M

Operating Income

$44.70M

EBITDA

$61.18M

Operating Cash Flow

$25.70M

Capital Expenditure

-$6.43M

Free Cash Flow

$19.27M

Cash & ST Invst.

$42.05M

Total Debt

$243.22M

TerrAscend Performance Analysis

TerrAscend annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 322,637,04832.5%
20232023-12-31USD 428,293,46532.7%
20242024-12-31USD 367,256,561-14.3%
20252025-12-31USD 364,074,714-0.9%
TerrAscend sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-300.1%
Q42025-12-313.2%
Q12026-03-31-4.0%
Q22026-06-301.4%
TerrAscend annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -1.76N/A
20232023-12-31USD -0.46-73.7%
20242024-12-31USD -0.38-18.3%
20252025-12-31USD -0.406.1%
TerrAscend sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-3052.9%
Q42025-12-31110.3%
Q12026-03-31-452.4%
Q22026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$65.39M

+0.6%

Gross Profit

$34.06M

+2.5%

Gross Margin

52.09%

N/A

Market Cap

CA$259.71MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

CA$278.36K

N/A

Employees

933

N/A

Net Income

-$8.92M

+81.9%

EBITDA

$15.92M

+4.7%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$42.05M

+52.0%

Total Debt

$243.22M

+0.4%

Accounts Receivable

$16.30M

-18.5%

Inventory

$39.12M

+10.5%

Long Term Debt

$228.07M

-0.9%

Short Term Debt

$15.14M

+25.8%

Return on Assets

-7.43%

N/A

Return on Invested Capital

9.11%

N/A

Free Cash Flow

$4.88M

+521.5%

Operating Cash Flow

$6.48M

+130.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
WEED.TOCanopy Growth Corporation
CA$1.45+1.40%
DR.TOMedical Facilities Corporation
CA$15.64-0.57%
OGI.TOOrganigram Global Inc.
CA$1.66-2.92%
XLY.TOAuxly Cannabis Group Inc.
CA$3.14-2.79%

Trending Stocks

Symbol / CompanyPricePrice Chg
BITOProShares Trust - ProShares Bitcoin ETF
$9.81+0.06%
SPCXSpace Exploration Technologies
$134.00-0.04%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.88-0.03%
IBITiShares Bitcoin Trust
$41.20+0.06%

Questions About TSND

What is the current price of TerrAscend?

TerrAscend is trading at CA$0.84 per share.

What is the 52-week range for TerrAscend?

Over the past 52 weeks, TerrAscend has traded between CA$0.53 and CA$2.00.

How much debt does TerrAscend have?

As of the most recent reporting period, TerrAscend reported total debt of $345.63M.

How much cash does TerrAscend have on hand?

TerrAscend reported $59.62M in cash and cash equivalents in its most recent financial results.

What is TerrAscend’s dividend yield?

TerrAscend does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services